We are live on ! Find out more
QIM

Quantitative Investment Management Portfolio holdings

AUM $963M
1-Year Est. Return 12.95%
This Fund
S&P 500
This Quarter Est. Return
+13.56%
1 Year Est. Return
+12.95%
3 Year Est. Return
+35.29%
5 Year Est. Return
+26.17%
10 Year Est. Return
+187.22%
AUM
$974M
AUM Growth
+$58.2M
Cap. Flow
-$10.9M
Cap. Flow %
-1.12%
Top 10 Hldgs %
26.89%
Holding
771
New
290
Increased
92
Reduced
111
Closed
277

Top Sells

Rank Stock Value
1
MMM icon
3M
MMM
+$27.1M
2
TSLA icon
Tesla
TSLA
+$22.4M
3
AAPL icon
Apple
AAPL
+$20.1M
4
MO icon
Altria Group
MO
+$17.5M
5
ABBV icon
AbbVie
ABBV
+$14.8M

Sector Composition

Rank Sector Weight
1 Healthcare 21.79%
2 Industrials 10.82%
3 Consumer Discretionary 9.75%
4 Technology 8.24%
5 Financials 7.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FRC
351
DELISTED
First Republic Bank
FRC
$457K 0.05%
4,318
-36,716
-89% -$3.77M
PSB
352
DELISTED
PS Business Parks, Inc.
PSB
$457K 0.05%
3,455
+1,470
+74% +$189K
CUZ icon
353
Cousins Properties
CUZ
$5.19B
$455K 0.05%
+15,283
New +$459K
JBLU icon
354
JetBlue
JBLU
$2.28B
$448K 0.05%
+41,179
New +$406K
SAN icon
355
Banco Santander
SAN
$201B
$448K 0.05%
+194,371
New +$425K
TRN icon
356
Trinity Industries
TRN
$2.49B
$448K 0.05%
+21,084
New +$406K
UGI icon
357
UGI
UGI
$7.74B
$448K 0.05%
14,105
-73,015
-84% -$2.21M
GL icon
358
Globe Life
GL
$14.2B
$447K 0.05%
+6,025
New +$457K
AL
359
DELISTED
Air Lease Corp
AL
$445K 0.05%
15,227
-16,642
-52% -$444K
PBYI icon
360
Puma Biotechnology
PBYI
$404M
$444K 0.05%
+42,643
New +$441K
NOVT icon
361
Novanta
NOVT
$5.08B
$443K 0.05%
+4,156
New +$386K
CWST icon
362
Casella Waste Systems
CWST
$5.71B
$442K 0.05%
+8,483
New +$405K
CRI icon
363
Carter's
CRI
$1.42B
$439K 0.05%
+5,447
New +$434K
MRCY icon
364
Mercury Systems
MRCY
$5.83B
$435K 0.04%
+5,531
New +$453K
SEM
365
DELISTED
Select Medical
SEM
$434K 0.04%
54,782
+25,004
+84% +$207K
TNL icon
366
Travel + Leisure Co
TNL
$4.66B
$434K 0.04%
+15,405
New +$417K
UHAL icon
367
U-Haul Holding Co
UHAL
$13.9B
$430K 0.04%
14,260
-210
-1% -$6.15K
VSAT icon
368
Viasat
VSAT
$10.6B
$424K 0.04%
11,070
-9,500
-46% -$386K
SVC
369
Service Properties Trust
SVC
$1.04B
$421K 0.04%
11,887
+7,578
+176% +$264K
BCE icon
370
BCE
BCE
$20.2B
$411K 0.04%
+9,847
New +$405K
SRE icon
371
Sempra
SRE
$57.9B
$408K 0.04%
+6,962
New +$428K
IP icon
372
International Paper
IP
$21.6B
$405K 0.04%
12,149
-123,067
-91% -$3.92M
ROST icon
373
Ross Stores
ROST
$80.5B
$405K 0.04%
+4,754
New +$431K
FXI icon
374
iShares China Large-Cap ETF
FXI
$4.37B
$396K 0.04%
+9,985
New +$389K
GEO icon
375
The GEO Group
GEO
$4.13B
$395K 0.04%
33,402
+16,334
+96% +$199K

Similar funds

Quantitative Investment Management's Q2 2020 Portfolio in Review

As of Q2 2020, Quantitative Investment Management held 771 positions worth $974M, up 6.4% from $916M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Quantitative Investment Management's Q2 2020 filing shows 290 new, 92 increased, 111 reduced and 277 closed positions. Its largest new stake was Advanced Micro Devices: 581,444 shares worth $30.6M. The largest sale was 3M, an estimated $27.1M.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 19% a quarter earlier, followed by Industrials and Consumer Discretionary.

  • Quantitative Investment Management's largest Q2 2020 buy was Advanced Micro Devices: 581,444 shares worth $30.6M.
  • Quantitative Investment Management added most to Pfizer in Q2 2020, an estimated $23M increase.
  • Quantitative Investment Management's biggest Q2 2020 reduction was 3M, cutting an estimated $27.1M.
  • Quantitative Investment Management fully exited Tesla in Q2 2020, selling an estimated $22.4M.
  • Quantitative Investment Management's ten largest holdings make up 27% of its $974M portfolio in Q2 2020.
  • Quantitative Investment Management opened 290 new positions and closed 277 in Q2 2020.
  • Quantitative Investment Management's portfolio value rose 6.4% quarter-over-quarter to $974M.

Based on Quantitative Investment Management's 13F filing for Q2 2020, filed 14 Aug 2020.